Loratadine: Difference between revisions
(Created page with "==Administration== *Type: H1 antagonists (second generation) *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== ===Pregnancy Rating=== * ===Lactation risk=== * ===Renal Dosing=== *Adult: *Pediatric: ===Hepatic Dosing=== *Adult: *Pediatric: ==Contraindications== *Allergy to class/drug ==Adverse Reactions== ===Serious=== ===Common=== ==Pharmacolo...") |
|||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: [[H1 antagonists]] (second generation) | *Type: [[H1 antagonists]] (second generation) | ||
*Dosage Forms: | *Dosage Forms: Tablets (chewable or orally disintegrating tablets [ODTs]), liquid-filled capsules, or a syrup (1 mg/mL solution) | ||
*Routes of Administration: Oral | *Routes of Administration: Oral | ||
*Common Trade Names: | *Common Trade Names: Claritin | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 21:19, 20 May 2026
Administration
- Type: H1 antagonists (second generation)
- Dosage Forms: Tablets (chewable or orally disintegrating tablets [ODTs]), liquid-filled capsules, or a syrup (1 mg/mL solution)
- Routes of Administration: Oral
- Common Trade Names: Claritin
Adult Dosing
Pediatric Dosing
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: